Literature DB >> 8823295

A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.

P J French1, J H van Doorninck, R H Peters, E Verbeek, N A Ameen, C R Marino, H R de Jonge, J Bijman, B J Scholte.   

Abstract

The most prevalent mutation (delta F508) in cystic fibrosis patients inhibits maturation and transfer to the plasma membrane of the mutant cystic fibrosis transmembrane conductance regulator (CFTR). We have analyzed the properties of a delta F508 CFTR mouse model, which we described recently. We show that the mRNA levels of mutant CFTR are normal in all tissues examined. Therefore the reduced mRNA levels reported in two similar models may be related to their intronic transcription units. Maturation of mutant CFTR was greatly reduced in freshly excised oviduct, compared with normal. Accumulation of mutant CFTR antigen in the apical region of jejunum crypt enterocytes was not observed, in contrast to normal mice. In cultured gallbladder epithelial cells from delta F508 mice, CFTR chloride channel activity could be detected at only two percent of the normal frequency. However, in mutant cells that were grown at reduced temperature the channel frequency increased to over sixteen percent of the normal level at that temperature. The biophysical characteristics of the mutant channel were not significantly different from normal. In homozygous delta F508 mice we did not observe a significant effect of genetic background on the level of residual chloride channel activity, as determined by the size of the forskolin response in Ussing chamber experiments. Our data show that like its human homologue, mouse delta F508-CFTR is a temperature sensitive processing mutant. The delta F508 mouse is therefore a valid in vivo model of human delta F508-CFTR. It may help us to elucidate the processing pathways of complex membrane proteins. Moreover, it may facilitate the discovery of new approaches towards therapy of cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823295      PMCID: PMC507556          DOI: 10.1172/JCI118917

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

Authors:  S H Cheng; R J Gregory; J Marshall; S Paul; D W Souza; G A White; C R O'Riordan; A E Smith
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

2.  Immunocytochemical localization of the cystic fibrosis gene product CFTR.

Authors:  I Crawford; P C Maloney; P L Zeitlin; W B Guggino; S C Hyde; H Turley; K C Gatter; A Harris; C F Higgins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

3.  Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.

Authors:  W Dalemans; P Barbry; G Champigny; S Jallat; K Dott; D Dreyer; R G Crystal; A Pavirani; J P Lecocq; M Lazdunski
Journal:  Nature       Date:  1991 Dec 19-26       Impact factor: 49.962

4.  Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes.

Authors:  M L Drumm; D J Wilkinson; L S Smit; R T Worrell; T V Strong; R A Frizzell; D C Dawson; F S Collins
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

5.  Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis.

Authors:  P W Cheng; T F Boat; K Cranfill; J R Yankaskas; R C Boucher
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2.

Authors:  R J Gregory; D P Rich; S H Cheng; D W Souza; S Paul; P Manavalan; M P Anderson; M J Welsh; A E Smith
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

7.  Genotypic analysis of respiratory mucous sulfation defects in cystic fibrosis.

Authors:  Y Zhang; B Doranz; J R Yankaskas; J F Engelhardt
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

8.  Quantitative expression patterns of multidrug-resistance P-glycoprotein (MDR1) and differentially spliced cystic-fibrosis transmembrane-conductance regulator mRNA transcripts in human epithelia.

Authors:  S Bremer; T Hoof; M Wilke; R Busche; B Scholte; J R Riordan; G Maass; B Tümmler
Journal:  Eur J Biochem       Date:  1992-05-15

9.  Immunocytochemical analysis reveals differences between the subcellular localization of normal and delta Phe508 recombinant cystic fibrosis transmembrane conductance regulator.

Authors:  W Dalemans; J Hinnrasky; P Slos; D Dreyer; C Fuchey; A Pavirani; E Puchelle
Journal:  Exp Cell Res       Date:  1992-07       Impact factor: 3.905

10.  Regulation of plasma membrane recycling by CFTR.

Authors:  N A Bradbury; T Jilling; G Berta; E J Sorscher; R J Bridges; K L Kirk
Journal:  Science       Date:  1992-04-24       Impact factor: 47.728

View more
  50 in total

1.  N-terminal transmembrane domain of the SUR controls trafficking and gating of Kir6 channel subunits.

Authors:  Kim W Chan; Hailin Zhang; Diomedes E Logothetis
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

2.  Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.

Authors:  Mark Bazett; Lisa Honeyman; Anguel N Stefanov; Christopher E Pope; Lucas R Hoffman; Christina K Haston
Journal:  Mamm Genome       Date:  2015-02-27       Impact factor: 2.957

3.  Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches.

Authors:  Anna Ermund; André Schütte; Malin E V Johansson; Jenny K Gustafsson; Gunnar C Hansson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-05       Impact factor: 4.052

4.  Vasoactive intestinal peptide, forskolin, and genistein increase apical CFTR trafficking in the rectal gland of the spiny dogfish, Squalus acanthias. Acute regulation of CFTR trafficking in an intact epithelium.

Authors:  R W Lehrich; S G Aller; P Webster; C R Marino; J N Forrest
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

5.  Rescue of epithelial HCO3- secretion in murine intestine by apical membrane expression of the cystic fibrosis transmembrane conductance regulator mutant F508del.

Authors:  Fang Xiao; Junhua Li; Anurag Kumar Singh; Brigitte Riederer; Jiang Wang; Ayesha Sultan; Henry Park; Min Goo Lee; Georg Lamprecht; Bob J Scholte; Hugo R De Jonge; Ursula Seidler
Journal:  J Physiol       Date:  2012-07-16       Impact factor: 5.182

6.  Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis.

Authors:  Folke Freudenberg; Monika R Leonard; Shou-An Liu; Jonathan N Glickman; Martin C Carey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

7.  Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis.

Authors:  Kazunori Shibao; Keiji Hirata; Marie E Robert; Michael H Nathanson
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

8.  Processing and function of CFTR-DeltaF508 are species-dependent.

Authors:  Lynda S Ostedgaard; Christopher S Rogers; Qian Dong; Christoph O Randak; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

9.  The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells.

Authors:  Antonius Bronckers; Lida Kalogeraki; Huub J N Jorna; Martina Wilke; Theodore J Bervoets; Donacian M Lyaruu; Behrouz Zandieh-Doulabi; Pamela Denbesten; Hugo de Jonge
Journal:  Bone       Date:  2009-12-30       Impact factor: 4.398

Review 10.  Ion channel associated diseases: overview of molecular mechanisms.

Authors:  Mark A Zaydman; Jonathan R Silva; Jianmin Cui
Journal:  Chem Rev       Date:  2012-11-14       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.